| James Love on Mon, 29 Mar 1999 23:02:11 +0200 (CEST) |
[Date Prev] [Date Next] [Thread Prev] [Thread Next] [Date Index] [Thread Index]
| <nettime> FT: Campaign over drug licensing to grow |
[orig to RANDOM-BITS <random-bits@essential.org>]
Financial Times
Monday, March 29, 1999
Lead paragraph on page one, full story on page 3
Campaign over drug licensing to grow
by Francis Williams in Geneva
Aids activists and other health and consumer groups plan to
step up their campaign against US government policy on
compulsory licensing of pharmaceuticals patents, which they
claim is depriving people in poor countries of life-saving
drugs.
Washington has threatened sanctions against countries such
as Thailand and South Africa for exercising what groups
claim are their legal rights to insist on compulsory
licenses for certain drugs which are not available or
affordable locally.
International patent law and world trade rules allow
governments to issue a compulsory license, enabling a local
company to produce a patented drug, if this is judged to be
in the public interest and reasonable terms cannot be
negotiated with the patent owner.
US policy came under a strong attack at a meeting on Friday
of some 60 non-governmental organizations from around the
world with representatives of the pharmaceutical industry,
governments and international bodies including the World
Health Organization (WHO) and the World Trade Organization
(WTO).
Bernard Pecoul of Medecins Sans Frontieres (MSF), which is
trying to improve access to essential drugs, said access had
worsened in recent years. The emergence of new diseases
such as HIV/Aids and drug resistant strains of old ones such
as tuberculosis or malaria meant that, increasingly,
effective drugs tended to be protected by patents.
Health groups say the drugs are too expensive or are not
sold in developing countries to avoid undercutting lucrative
markets in the US and Europe. The big US and European
pharmaceutical companies argue that compulsory licensing
acts as a disincentive to research and development.
---
# distributed via nettime-l : no commercial use without permission
# <nettime> is a closed moderated mailinglist for net criticism,
# collaborative text filtering and cultural politics of the nets
# more info: majordomo@desk.nl and "info nettime-l" in the msg body
# URL: http://www.desk.nl/~nettime/ contact: nettime-owner@desk.nl